Cargando…
Hydroxychloroquine/oseltamivir: Exacerbation of psoriasis during off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516239/ http://dx.doi.org/10.1007/s40278-020-83819-8 |
Ejemplares similares
-
Azithromycin/hydroxychloroquine/oseltamivir: Urticarial reactions following off label use: case report
Publicado: (2020) -
Hydroxychloroquine/oseltamivir: Various toxicity following off label therapy: case report
Publicado: (2020) -
Favipiravir/hydroxychloroquine/oseltamivir: Tonic clonic seizures following off label use: case report
Publicado: (2020) -
Azithromycin/hydroxychloroquine off label use: Pustular psoriasis following misuse: case report
Publicado: (2022) -
Oseltamivir: Immune thrombocytopenic purpura following off-label use: case report
Publicado: (2020)